| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/24/2023 | 18.64% | Truist Securities | $10 → $7 | Maintains | Hold |
| 10/03/2023 | -15.25% | Goldman Sachs | $6 → $5 | Maintains | Sell |
| 09/18/2023 | 69.49% | Evercore ISI Group | → $10 | Initiates Coverage On | → Outperform |
| 08/01/2023 | 1.69% | Goldman Sachs | $4 → $6 | Maintains | Sell |
| 07/25/2023 | 69.49% | Truist Securities | $8 → $10 | Maintains | Hold |
| 06/08/2023 | -66.1% | Wolfe Research | → $2 | Downgrades | Peer Perform → Underperform |
| 04/28/2023 | 35.59% | Deutsche Bank | $10 → $8 | Maintains | Hold |
| 04/13/2023 | -32.2% | Goldman Sachs | $5 → $4 | Maintains | Sell |
| 04/12/2023 | -32.2% | Goldman Sachs | $5 → $4 | Maintains | Sell |
| 01/25/2023 | -49.15% | Morgan Stanley | $4 → $3 | Maintains | Underweight |
| 12/14/2022 | -15.25% | Goldman Sachs | $8 → $5 | Downgrades | Neutral → Sell |
| 11/10/2022 | -32.2% | Morgan Stanley | $12 → $4 | Downgrades | Equal-Weight → Underweight |
| 11/01/2022 | 35.59% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
| 10/11/2022 | 52.54% | Goldman Sachs | $11 → $9 | Maintains | Neutral |
| 09/29/2022 | 69.49% | Truist Securities | → $10 | Initiates Coverage On | → Hold |
| 07/14/2022 | 103.39% | Morgan Stanley | $30 → $12 | Maintains | Equal-Weight |
| 06/01/2022 | 103.39% | Goldman Sachs | $17 → $12 | Maintains | Neutral |
| 04/12/2022 | 238.98% | Deutsche Bank | → $20 | Initiates Coverage On | → Hold |
| 03/29/2022 | 238.98% | SMBC Nikko | → $20 | Initiates Coverage On | → Neutral |
| 02/23/2022 | 408.47% | Morgan Stanley | $40 → $30 | Maintains | Equal-Weight |
| 02/22/2022 | 357.63% | JP Morgan | $40 → $27 | Maintains | Neutral |
| 11/16/2021 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 07/21/2021 | 493.22% | JP Morgan | → $35 | Initiates Coverage On | → Neutral |
| 06/17/2021 | 323.73% | Wolfe Research | → $25 | Initiates Coverage On | → Peer Perform |
| 03/09/2021 | 866.1% | Cowen & Co. | → $57 | Initiates Coverage On | → Outperform |
| 03/04/2021 | 781.36% | Baird | → $52 | Initiates Coverage On | → Neutral |
| 02/12/2021 | 1086.44% | Morgan Stanley | → $70 | Initiates Coverage On | → Overweight |
| 02/05/2021 | 611.86% | Goldman Sachs | → $42 | Initiates Coverage On | → Neutral |
| 11/30/2020 | 374.58% | Bernstein | → $28 | Initiates Coverage On | → Underperform |
What is the target price for QuantumScape (QS)?
The latest price target for QuantumScape (NYSE: QS) was reported by Truist Securities on October 24, 2023. The analyst firm set a price target for $7.00 expecting QS to rise to within 12 months (a possible 18.64% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for QuantumScape (QS)?
The latest analyst rating for QuantumScape (NYSE: QS) was provided by Truist Securities, and QuantumScape maintained their hold rating.
When is the next analyst rating going to be posted or updated for QuantumScape (QS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of QuantumScape, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for QuantumScape was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.
Is the Analyst Rating QuantumScape (QS) correct?
While ratings are subjective and will change, the latest QuantumScape (QS) rating was a maintained with a price target of $10.00 to $7.00. The current price QuantumScape (QS) is trading at is $5.90, which is out of the analyst's predicted range.